Correlation Analysis of Computed Tomography Features and Pathological Types of Multifocal Ground-Glass Nodular Lung Adenocarcinoma

por Kou, Jieli, Gu, Xiaofei, Kang, Liqing
Publicado 2022

Application of a novel targeting nanoparticle contrast agent combined with magnetic resonance imaging in the diagnosis of intraductal papillary mucinous neoplasm

por Sun, Min, Kang, Liqing, Cui, Yanchao, Li, Guoce
Publicado 2018

Radiomics Based on CECT in Differentiating Kimura Disease From Lymph Node Metastases in Head and Neck: A Non-Invasive and Reliable Method

por Zhang, Ying, Yu, Shujing, Zhang, Li, Kang, Liqing
Publicado 2020

Study on the Value of DCE-MRI in Differentiating Glossitis and Tongue Cancer and the Intratumour Heterogeneity

por Liu, Fenghai, Zhao, Meng, Lu, Shan, Kang, Liqing
Publicado 2021

Effects of Different Delivery Modes on Pelvic Floor Function in Parturients 6–8 Weeks after Delivery Using Transperineal Four-Dimensional Ultrasound

por Wang, Chao, Wang, Qirong, Zhao, Xuemei, Wang, Xia, Zhou, Wenji, Kang, Liqing
Publicado 2022

Delayed remission following sequential infusion of humanized CD19- and CD22-modified CAR-T cells in a patient with relapsed/refractory acute lymphoblastic leukemia and prior exposu...

por Yang, Fei, Zhang, Jian, Zhang, Xinyou, Tian, Mengli, Wang, Jingjing, Kang, Liqing, Qiu, Huiying, Wu, Depei
Publicado 2019

Prediction of severe CRS and determination of biomarkers in B cell-acute lymphoblastic leukemia treated with CAR-T cells

por Wei, Zhenyu, Xu, Jiayu, Zhao, Chengkui, Zhang, Min, Xu, Nan, Kang, Liqing, Lou, Xiaoyan, Yu, Lei, Feng, Weixing
Publicado 2023

CAR-T therapy alters synthesis of platelet-activating factor in multiple myeloma patients

por Ke, Mengying, Kang, Liqing, Wang, Ling, Yang, Shu, Wang, Yajun, Liu, Haiyan, Gu, Chunyan, Huang, Hongming, Yang, Ye
Publicado 2021

Investigation of CRS-associated cytokines in CAR-T therapy with meta-GNN and pathway crosstalk

por Wei, Zhenyu, Cheng, Qi, Xu, Nan, Zhao, Chengkui, Xu, Jiayu, Kang, Liqing, Lou, Xiaoyan, Yu, Lei, Feng, Weixing
Publicado 2022

Long-term Complete Remission of Decitabine-Primed Tandem CD19/CD22 CAR-T Therapy with PD-1 and BTK Inhibitors Maintenance in a Refractory Primary Central Nervous System Lymphoma Pa...

por Zou, Rui, Zhou, Xiao, Liu, Hailing, Wang, Peng, Xia, Fan, Kang, Liqing, Yu, Lei, Wu, Depei, Jin, Zhengming, Qu, Changju
Publicado 2023

Inhibition of Cholesterol Esterification Enzyme Enhances the Potency of Human Chimeric Antigen Receptor T Cells against Pancreatic Carcinoma

por Zhao, Lei, Liu, Yang, Zhao, Fuya, Jin, Ye, Feng, Jing, Geng, Rui, Sun, Jiayu, Kang, Liqing, Yu, Lei, Wei, Yunwei
Publicado 2020

Prognostic value of the SYNTAX score on myocardial injury and salvage in STEMI patients after primary percutaneous coronary intervention: a single-center retrospective observationa...

por Gao, Guangren, Feng, Lianrong, Fu, Jinguo, Li, Yi, Huo, Zhaoyang, Zhang, Lei, Wang, Lei, Niu, Heping, Kang, Liqing, Zhang, Jun
Publicado 2021

Pre-clinical efficacy of CD20-targeted chimeric antigen receptor T cells for non-Hodgkin's lymphoma

por Wen, Hairuo, Lou, Xiaoyan, Qu, Zhe, Qin, Chao, Jiang, Hua, Yang, Ying, Kang, Liqing, Geng, Xingchao, Yu, Lei, Huang, Ying
Publicado 2022

P357: DECITABINE CONSOLIDATION AFTER CD19/CD22 CAR-T THERAPY IS A NOVEL STRATEGY TO IMPROVE OUTCOMES IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

por LI, Tingting, Cui, Qingya, Liu, Sining, LI, Zheng, Cui, Wei, LI, Mengyun, Zhu, Xiaming, Kang, Liqing, Yu, Lei, Wu, Depei, Tang, Xiaowen
Publicado 2023

Preclinical efficacy and safety evaluation of interleukin-6-knockdown CAR-T cells targeting at CD19

por Wen, Hairuo, Huo, Guitao, Hou, Tiantian, Qu, Zhe, Sun, Juanjuan, Yu, Zhou, Kang, Liqing, Wang, Manhong, Lou, Xiaoyan, Yu, Lei, Huo, Yan
Publicado 2021

Immunoglobulin isotype switch after anti-BCMA CAR T-cell therapy for relapsed or refractory multiple myeloma

por Liang, Zhiyu, Li, Ping, Kang, Liqing, Zhou, Lili, Xu, Yang, Ye, Shiguang, Du, Juan, Li, Bing, Wang, Yiwen, Yu, Lei, Qian, Wenbin, Liang, Aibin
Publicado 2022

Decitabine-primed tandem CD19/CD22 CAR-T therapy in relapsed/refractory diffuse large B-cell lymphoma patients

por Qu, Changju, Zou, Rui, Wang, Peng, Zhu, Qian, Kang, Liqing, Ping, Nana, Xia, Fan, Liu, Hailing, Kong, Danqing, Yu, Lei, Wu, Depei, Jin, Zhengming
Publicado 2022

Decitabine in combination with fludarabine and cyclophosphamide as a lymphodepletion regimen followed by CD19/CD22 bispecific targeted CAR T-cell therapy significantly improves sur...

por Ma, Yunju, Dai, Haiping, Cui, Qingya, Liu, Sining, Kang, Liqing, Lian, Xiaying, Cui, Wei, Yin, Jia, Liu, Lingling, Cai, Mengjie, Yu, Lei, Wu, Depei, Tang, Xiaowen
Publicado 2023

Overall survival benefits provided by lenalidomide maintenance after chimeric antigen receptor T cell therapy in patients with refractory/relapsed diffuse large B-cell lymphoma

por Ping, Nana, Qu, Changju, Li, Mengyun, Kang, Liqing, Kong, Danqin, Chen, Xiaochen, Wu, Qian, Xia, Fan, Yu, Lei, Yao, Hong, Yan, Lingzhi, Wu, Depei, Jin, Zhengming
Publicado 2022

Successful treatment of marrow failure after CARTs for myeloma by the infusion of cryopreserved stem cells

por Yan, Lingzhi, Shang, Jingjing, Shi, Xiaolan, Kang, Huizhu, Liu, Wei, Xu, Nan, Liu, Yong, Chen, Guanghua, Kang, Liqing, Gong, Feiran, Tang, Fang, Yu, Lei, Wu, Depei, Fu, Chengcheng
Publicado 2019